CHRISTIANS ENJOINED TO SEEK GOD'S FACE DESIST FROM NEGOTIATING ONE'S DESTINY WITH THE DEVIL. (PHOTO). #PRESS RELEASE

Image
 Christians enjoined to seek God's face desist from negotiating one's destiny with the devil By Ezumezu Nonyelum  Christians enjoined to seek God's face desist from negotiating one's destiny with the devil. Converts encouraged to refrain from secret sin that deprives them from mercy of God. The Officiating Priest of St. Michael Parish Awkuzu, Rev. Fr. Michael Okoye stated this in a homily during a 6.00am mass on November 15. Fr. Michael Okoye hinted that some Catholic faithfuls have deny their destiny for worldly pleasures, sins, money to satisfy their flesh. He reflects on Mathew's Gospel that"  fear is debilitating indeed". The other servants who were not governed by fear took risk and made wonderful returns", he said. Fr. Okoye emphasized in the parable of 5 talents, 2 talents and 1 talent that Christians should not seen others most favoured than others. He added that some human being regard themselves as less endowed for achieving the purpose for ...

ZIMBABWE ROLLS OUT NEW HIV PREVENTION DRUG LENACAPAVIR. (PHOTO)


 Zimbabwe rolls out new HIV prevention drug lenacapavir


Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections.


Health Minister Douglas Mombeshora said the programme, funded by the U.S. and the Global Fund, would initially target more than 46,000 people at high risk of contracting HIV across 24 sites nationwide.


"Today marks an important day in Zimbabwe's national response to HIV. We gather here to launch lenacapavir - a long-acting injectable option for HIV prevention - and to show our commitment to protecting life and ending AIDS as a public health threat," Mombeshora said, Reuters reported.


He said Zimbabwe received its first batch and injected some early adopters earlier this month, adding that the rollout would be done in phases.


Significant progress


Lenacapavir, developed by Gilead Sciences, is administered as a subcutaneous injection twice a year. Officials say it could help overcome adherence challenges associated with daily oral pre-exposure prophylaxis (PrEP) pills.


Zimbabwe has made significant progress in tackling HIV, achieving the 95-95-95 treatment targets set by U.N. programme UNAIDS — meaning 95% of people living with HIV know their status, 95% of those diagnosed are on treatment, and 95% of those on treatment have suppressed viral loads.


Melody Dengu, a community leader in the Harare suburb of Epworth, said she had already received the jab earlier this month.


"I have also (so far) gotten 12 other people to come and get injected," she told Reuters at the event.


Zimbabwe has one of Africa's highest HIV burdens, though new infections have declined significantly over the past decade due to expanded testing, treatment and prevention.

Comments

Popular posts from this blog

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.